Updated
Updated · Yahoo Finance · Aug 23
Cardinal Health Pharma Chief Sells 7,354 Shares for $1.7 Million, Still Holds $18.3 Million Stake
Updated
Updated · Yahoo Finance · Aug 23

Cardinal Health Pharma Chief Sells 7,354 Shares for $1.7 Million, Still Holds $18.3 Million Stake

1 articles · Updated · Yahoo Finance · Aug 23

Summary

  • $1.7 million of Cardinal Health stock was sold by Pharma segment CEO Deborah Weitzman, according to a recent SEC Form 4 filing covering 7,354 shares.
  • The sale cut her directly held position by about 9%, leaving 77,901 shares valued at roughly $18.31 million based on the August 18 close.
  • Those shares were sold at a weighted average price of $235.45, with individual trades executed between $235.17 and $237.63.
  • Cardinal Health shares closed at $234.85 on August 19, giving the healthcare distributor a market value of about $55.0 billion.
  • The filing comes as Cardinal Health remains a giant in healthcare distribution, with trailing 12-month revenue of $254.2 billion and net income of $1.7 billion.

Insights

Why is Cardinal Health's pharma chief suddenly cashing out $1.7 million just as the company projects massive 2027 growth?
As Cardinal aggressively expands into home care, does this insider sale signal hidden risks in their $360 million acquisition spree?